PMC/OraVax To Begin Phase I Studies For H. Pylori Vaccine in 1999
Executive Summary
Pasteur Merieux Connaught plans to begin Phase I studies of its H. pylori vaccine in 1999, PMC Exec VP-R&D Alf Lindberg told a meeting of securities analysts in New York City Nov. 19.